Results for the substance pegcetacoplan

Pegcetacoplan is a medication used for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a rare blood disorder characterized by the destruction of red blood cells. It is a C3 complement inhibitor that helps prevent red blood cell destruction and reduces disease symptoms.

The medication is administered as a subcutaneous injection, as directed by your doctor. It is important to follow the administration schedule and monitor for any adverse reactions.

Side effects may include injection site reactions, infections, fatigue, or headache. In rare cases, severe reactions such as serious infections caused by encapsulated bacteria may occur.

Patients should inform their doctor about any other medications being used or pre-existing conditions to ensure the safe use of pegcetacoplan.